(Q58860165)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21683110%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

title

A new oral vaccine candidate based on the microencapsulation by spray-drying of inactivated Vibrio cholerae (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21683110%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

0 references

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21683110%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Sergio Sifontes

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21683110%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

author name string

Gemma Año

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21683110%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Marta Pastor

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21683110%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Arturo Talavera

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21683110%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Bárbara Cedré

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21683110%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Sonsire Fernández

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21683110%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Yisabel Aranguren

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21683110%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Gustavo Falero

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21683110%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Luis García

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21683110%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Rosa Lydia Solís

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21683110%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

José Luis Pedraz

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21683110%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

language of work or name

English

0 references

publication date

15 June 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21683110%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

number of pages

7

1 reference

based on heuristic

inferred from page(s)

published in

Vaccine

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21683110%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

volume

29

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21683110%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

issue

34

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21683110%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

page(s)

5758-5764

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21683110%20AND%20SRC:MED&resulttype=core&format=json

The true burden and risk of cholera: implications for prevention and control

5 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.098

Is cholera disease associated with poverty?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.098

Effectiveness of mass oral cholera vaccination in Beira, Mozambique

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.098

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.098

Formulation in tablets of a cholera whole cells inactivated vaccine candidate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.098

Oral cholera vaccines: use in clinical practice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.098

Long-term effectiveness against cholera of oral killed whole-cell vaccine produced in Vietnam

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.098

Field trial of a locally produced, killed, oral cholera vaccine in Vietnam

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.098

Questionable merits of the field trial of an oral killed whole cell cholera vaccine in Vietnam during 1998-2003

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.098

Delivery systems and adjuvants for oral vaccines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.098

Inactive Vibrio cholerae whole-cell vaccine-loaded biodegradable microparticles: in vitro release and oral vaccination.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.098

Protective effects of oral microencapsulated Mycoplasma hyopneumoniae vaccine prepared by co-spray drying method

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.098

Production of Eudragit Microparticles by Spray-Drying Technique: Influence of Experimental Parameters on Morphological and Dimensional Characteristics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.098

Spray dried Eudragit microparticles as encapsulation devices for vitamin C.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.098

Spray-dried mucoadhesive microspheres: preparation and transport through nasal cell monolayer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.098

Mucosal or parenteral administration of microsphere-associated Bacillus anthracis protective antigen protects against anthrax infection in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.098

The ABCs (Antibody, B cells, and Carbohydrate epitopes) of cholera immunity: considerations for an improved vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.098

Evaluation of the protective efficacy of Vibrio cholerae ghost (VCG) candidate vaccines in rabbits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.098

Retained integrity of protein encapsulated in spray-dried chitosan microparticles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.098

Production of BSA-loaded alginate microcapsules: influence of spray dryer parameters on the microcapsule characteristics and BSA release

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.098

Sodium pantoprazole-loaded enteric microparticles prepared by spray drying: Effect of the scale of production and process validation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.098

Oral delivery of gastro-resistant microencapsulated typhoid vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.098

Polymeric particulates to improve oral bioavailability of peptide drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.098

Mucosal delivery of vaccine antigens and its advantages in pediatrics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.098

Microencapsulated subunit vaccine approach to enterotoxigenic Escherichia coli and other mucosal pathogens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.098

Oral immunogenicity of the inactivated Vibrio cholerae whole-cell vaccine encapsulated in biodegradable microparticles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.098

Passive protection of serum from volunteers inoculated with attenuated strain 638 of Vibrio cholerae O1 in animal models

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.098

Tablet formulation study of spray-dried sodium diclofenac enteric-coated microcapsules

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.098

Incomplete correlation of serum vibriocidal antibody titer with protection from Vibrio cholerae infection in urban Bangladesh

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.098

Broad up-regulation of innate defense factors during acute cholera

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.098

The vaccine candidate Vibrio cholerae 638 is protective against cholera in healthy volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.098

Process development for a Cuban cholera vaccine based on the attenuated strain Vibrio cholerae 638.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.098

Preliminary assessment of the safety and immunogenicity of a new CTXPhi-negative, hemagglutinin/protease-defective El Tor strain as a cholera vaccine candidate.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.098

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2011.05.098

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21683110%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

1 reference